Search Results
All Content Formulary Only Other ContentWe have found 12 results when searching "Certolizumab pegol"
PATHWAY
Psoriatic Arthritis : Treatment of Psoriatic Arthritis with biologics in pregnancy
Biologic therapies may be initiated by rheumatologists in patients who have not responded to conventional DMARDs in line with British Society for Rheumatology guidance.
PATHWAY
Axial Spondyloarthritis : Treatment of Axial Spondyloarthritis in pregnancy
Biologic therapies may be initiated by rheumatologists in patients who have not responded to conventional DMARDs in line with British Society for Rheumatology guidance.
PATHWAY
Psoriasis : Biologic treatment of chronic plaque psoriasis in pregnancy
PATHWAY
Psoriasis : Biologic treatment of chronic plaque psoriasis with inflammatory bowel disease
PATHWAY
Psoriasis : Biologic treatment of psoriasis with psoriatic arthritis
PATHWAY
Psoriasis : Biologic treatment of chronic plaque psoriasis
FORMULARY DECISION
Certolizumab pegol : Cimzia
TA375 (SMC 590/09) : Moderate to severe active rheumatoid arthritis in adult patients.
FORMULARY DECISION
Certolizumab pegol : Cimzia
TA383 (SMC 960/14) : For the treatment of adult patients with severe active axial spondyloarthritis.
FORMULARY DECISION
Certolizumab pegol : Cimzia
TA445 (SMC 973/14) : In combination with methotrexate, for the treatment of active psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug (DMARD) therapy has ...